Certified Excellence
Trusted by industry leaders
What We Build for Pharmaceutical Operations
We design and build software across the four areas pharma companies most often need replaced or unified, each engineered to hold validation evidence from day one rather than retrofitted before an audit.
Clinical Trial Management Systems
We build CTMS platforms covering protocol design, patient enrollment tracking, multi-site investigator coordination, and automated protocol deviation alerts, structured around your trial’s actual monitoring cadence rather than a generic workflow template.
Regulatory Submission & Compliance Software
Our teams build FDA, EMA, and ICH submission workflow automation with 21 CFR Part 11 compliant e-signatures, version-controlled SOP repositories, and audit trails that hold up to inspection without manual reconstruction.
Pharmacovigilance & Drug Safety Platforms
We build adverse event capture and classification systems with MedDRA-coded signal detection dashboards, giving safety teams a structured intake pipeline instead of spreadsheet-based case tracking that breaks under volume.
Supply Chain & Serialization Software
We build DSCSA-aligned traceability platforms supporting EPCIS-based data exchange at the saleable unit level, cold chain monitoring, and vendor procurement automation built for 2026’s full enforcement requirements.
Have a Pharma Platform That Needs to Pass Validation Review?
Get a scoped assessment of what your build actually requires before a single sprint starts.
Get a Validation Scoping CallWhy Off-the-Shelf and Legacy ERP Tools Fail Under GxP Scrutiny
DSCSA’s enhanced drug distribution security requirements are now fully enforced for manufacturers, wholesale distributors, and large dispensers, with only small dispensers still under exemption through November 2026. Generic ERP modules and repurposed pharmacy software were never built for saleable-unit serialization, EPCIS data exchange, or the audit trail granularity inspectors now expect.
Meanwhile, FDA’s Computer Software Assurance guidance, finalized in September 2025, shifted how validation effort gets demonstrated. Teams still running exhaustive scripted testing on every system change are spending validation budget the new guidance no longer requires, while teams without a validated software partner are stuck retrofitting evidence after a system is already in production.
What Goes Into a Validated Pharma Software Platform
Tamper-Evident Audit Trails
Every record change is computer-generated, time-stamped, and immutable, reviewed against a documented schedule rather than relying on staff discipline to flag discrepancies.
Role-Based Access and E-Signatures
Unique user IDs, system-enforced password policy, and 21 CFR Part 11-compliant e-signatures bound to signer identity, date, and signature meaning at every event.
Structured Change Control
Every system change carries an impact assessment and re-validation trigger, so a single update doesn't quietly invalidate three other workflows downstream.
Risk-Based Validation Documentation
IQ/OQ/PQ protocols scaled to system risk under GAMP 5 and CSA principles, not a one-size-fits-all testing script applied regardless of complexity.
How Much Does It Cost to Develop Pharma Software?
Most validated pharma platforms run between $35,000 and $150,000+ depending on regulatory scope and integration depth.
Get a transparent estimate after a free discovery session.
Integration Capabilities for Pharma Software Platforms
Who We Build Pharma Software For
We design platforms around the specific compliance and operational pressure each segment of the industry actually faces.
How We Deliver a Validated Pharma Platform
Discover
We run structured discovery sessions with your regulatory, clinical, and IT stakeholders to map existing workflows, document compliance gaps, and produce a validated requirements document before any code is written. This step alone surfaces most of the downstream validation risk a project will carry.
Design
Our architecture and UX teams design role-based interfaces aligned to how scientists, compliance officers, and supply chain staff actually move through a workday, with the system structure itself reflecting your GxP categorization from the start.
Build with Embedded Validation
Engineers build on GAMP 5-aligned frameworks under our Secure ADLC methodology, generating change control records, test evidence, and audit trail logic as a byproduct of development rather than a separate documentation pass at the end.
Validate
We execute IQ/OQ/PQ protocols scaled to system risk per CSA guidance, producing the validation package your QA team needs for sign-off without redundant scripted testing on low-risk components.
Deploy and Support
We deploy with full regulatory documentation, team onboarding, and a structured post-launch support plan covering revalidation triggers as your regulatory landscape and compound pipeline evolve.
Compliance Coverage Across Your Regulatory Obligations
We build directly against the standards governing your specific operations, not a generic compliance checklist.
| Standard | Scope | Who Needs It | Our Coverage |
|---|---|---|---|
|
21 CFR Part 11 |
Electronic records and e-signatures |
All FDA-regulated software |
Full |
|
GxP / GAMP 5 |
Risk-based system validation |
Manufacturing, clinical, lab systems |
Full |
|
DSCSA / EPCIS |
Saleable-unit drug traceability |
Manufacturers, distributors, dispensers |
Full |
|
EU Annex 11 |
Computerized system control, EU markets |
Dual-jurisdiction operations |
Full |
|
HIPAA |
Protected health data |
Patient-facing or PHI-adjacent systems |
Full |
Serialization Software Built for Full Enforcement
Most vendors still describe DSCSA as an upcoming requirement. It is not. Manufacturers, wholesale distributors, and large dispensers are already under full enforcement, and only small dispensers remain exempt through November 2026.
-
EPCIS-based unit-level data exchange
-
Verification router network connectivity
-
Exception handling and quarantine workflows
-
Saleable returns automation
Ready to Replace Fragmented, Paper-Based Compliance Processes?
Get a platform engineered for the regulatory and operational demands of your business.
Schedule a Free ConsultationWhy Pharma Teams Choose Citrusbug
Validation evidence is generated during the build under our Secure ADLC methodology, not assembled after the fact when an audit is already scheduled.
Experienced senior engineers who understand GxP workflows are assigned before you sign, not generalist contractors learning pharma terminology on your project timeline.
Discovery sessions map your actual regulatory and QA processes first, so the system mirrors your SOPs instead of forcing your team to adapt to a generic template.
Full source code ownership and complete validation documentation are handed over at delivery, with no vendor dependency for your next audit cycle.
Client Testimonials (We're Rated 4.7 on Clutch)
Healthcare Platforms We've Delivered
Droice Labs
AI-based personal health monitoring and preventive care platform designed to transform diverse clinical and patient data into actionable insights.
View Case Study →Insights From Our Team
VIEW ALL
Custom NLP Solutions for Healthcare: Revolutionizing Patient Interaction
The healthcare sector is changing quickly in order to streamline and expedite operations. People have noticed significant changes in the healthcare industry since NLP was introduced. AI software development makes…
Read Article →
ERP in Healthcare: Transforming Operations and Patient Care in 2026
Operational efficiency and patient-centric healthcare are not optional in the modern healthcare environment. They are important for success and survival. In order to provide better patient experiences leveraged by effortless…
Read Article →
Healthcare Automation Market Shifts Every Healthcare Organization Should Know
The healthcare automation market is undergoing rapid transformation as providers seek efficiency, accuracy, and scalability in an increasingly complex healthcare landscape. It’s no longer just forms that are being digitized…
Read Article →Frequently Asked Questions
How long does a validated pharma platform take to build and approve for use?
Most projects complete in 4 to 9 months. A focused module like an adverse event intake system can ship in around 3 months; enterprise platforms with multi-system integration take longer.
Do you provide IQ/OQ/PQ documentation as part of the engagement?
Yes. We produce complete Installation, Operational, and Performance Qualification protocols scaled to system risk under GAMP 5 and current CSA guidance, ready for your QA sign-off.
Can the platform integrate with Veeva Vault or Oracle Clinical One without custom middleware?
We build native integration layers for both platforms, along with SAP, LIMS systems, and MedDRA dictionaries, avoiding fragile middleware that breaks on vendor updates.
What happens if a regulatory requirement changes mid-build?
Our change control process documents the impact assessment and triggers re-validation only where genuinely required, so a regulatory shift doesn't force a full project restart.
How do you handle DSCSA serialization data exchange requirements?
We build EPCIS-based unit-level traceability with verification router network connectivity and documented exception handling workflows aligned to 2026 enforcement requirements.
Is the audit trail tamper-evident and ready for FDA inspection on day one?
Yes. Every record change is computer-generated, time-stamped, and immutable from the first production deployment, with a documented review schedule built into the system.
What does the engagement cost and how is the estimate built?
Cost depends on regulatory scope, system integrations, and validation requirements. We provide a transparent estimate after a no-charge discovery session, not a generic price range upfront.
Do you support both FDA and EMA dual-jurisdiction requirements?
Yes. We build systems that satisfy 21 CFR Part 11 and EU Annex 11 independently rather than treating one as a subset of the other, since the requirements diverge.